C4 Therapeutics, Inc. (CCCC)
4.11
+0.11
(+2.75%)
USD |
NASDAQ |
Aug 24, 16:00
4.07
-0.04
(-0.97%)
After-Hours: 20:00
C4 Therapeutics Price to Book Value : 2.043 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.988 |
| August 20, 2026 | 2.003 |
| August 19, 2026 | 2.093 |
| August 18, 2026 | 2.078 |
| August 17, 2026 | 2.12 |
| August 14, 2026 | 2.108 |
| August 13, 2026 | 2.028 |
| August 12, 2026 | 1.938 |
| August 11, 2026 | 1.924 |
| August 10, 2026 | 1.799 |
| August 07, 2026 | 1.854 |
| August 06, 2026 | 1.809 |
| August 05, 2026 | 1.799 |
| August 04, 2026 | 1.794 |
| August 03, 2026 | 1.740 |
| July 31, 2026 | 1.730 |
| July 30, 2026 | 1.819 |
| July 29, 2026 | 1.750 |
| July 28, 2026 | 1.765 |
| July 27, 2026 | 1.784 |
| July 24, 2026 | 1.69 |
| July 23, 2026 | 1.814 |
| July 22, 2026 | 1.859 |
| July 21, 2026 | 1.904 |
| July 20, 2026 | 1.780 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.834 |
| July 16, 2026 | 1.780 |
| July 15, 2026 | 1.889 |
| July 14, 2026 | 1.894 |
| July 13, 2026 | 1.948 |
| July 10, 2026 | 2.018 |
| July 09, 2026 | 2.132 |
| July 08, 2026 | 2.083 |
| July 07, 2026 | 2.162 |
| July 06, 2026 | 2.058 |
| July 02, 2026 | 2.137 |
| July 01, 2026 | 2.157 |
| June 30, 2026 | 2.321 |
| June 29, 2026 | 1.932 |
| June 26, 2026 | 1.892 |
| June 25, 2026 | 1.954 |
| June 24, 2026 | 1.888 |
| June 23, 2026 | 1.874 |
| June 22, 2026 | 1.830 |
| June 18, 2026 | 1.843 |
| June 17, 2026 | 1.741 |
| June 16, 2026 | 1.706 |
| June 15, 2026 | 1.697 |
| June 12, 2026 | 1.732 |
| June 11, 2026 | 1.719 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cartesian Therapeutics, Inc. | -- |
| Beam Therapeutics, Inc. | 2.742 |
| Rallybio Corp. | 0.9435 |
| Q32 Bio, Inc. | 3.662 |
| Arrowhead Pharmaceuticals, Inc. | 26.30 |
Price to Book Value Related Metrics
| PS Ratio | 13.08 |
| Price | 4.11 |
| Earnings Yield | -24.30% |
| Market Cap | 505.14M |